Phage Therapy: A Potential Novel Therapeutic Treatment of MRSA

Abstract

The emergence of multi-drug resistant bacterial strains, especially in the clinical setting has renewed interest in alternative therapeutic treatment methods. The utilization of prokaryotic viruses in phage therapy has demonstrated potential as a novel treatment method against multidrug resistant bacterial infections. As the post-antibiotic era quickly approaches the development and standardization of phage therapy is critically relevant to public health. This review serves to highlight the development of phage therapy against methicillin resistant Staphylococcus aureus (MRSA), an antibiotic resistant bacterial strain responsible for severe clinical infections.